Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell BioNTech SE - ADR (BNTX) – BioNTech SE - ADR Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

BioNTech (BNTX) trades at $88.50, showing minimal daily movement but facing significant fundamental challenges. The company reported a net loss of $1.14B in 2025 with a negative net margin of 44.64%, reflecting the sharp decline in COVID-19 vaccine revenue. Recent quarterly earnings have been mixed, with Q1 2026 beating expectations but Q4 2025 missing. Technically, the stock shows bearish momentum with moving averages signaling sell pressure, while the company undergoes a major restructuring including site closures and workforce reductions affecting 1,860 staff.
The investment outlook remains challenging as BioNTech transitions from pandemic windfalls to sustainable oncology growth. While the company maintains a strong cash position of $16.78B and analyst consensus remains bullish (87.5% buy ratings) with a $127.50 price target, near-term profitability concerns and pipeline execution risks create substantial uncertainty. The planned $1B share buyback program and promising oncology pipeline data provide potential catalysts, but investors face significant volatility during this transition period.
Read full analysis

Key Stats

  • Market Cap
    $22.66B
  • Sector
    Health
  • 3M Drawdown
    -21.34%
  • Enterprise Value
    $6.01B
  • Dividend Yield
    -
  • Trading Activity
    5% Buy | 95% Sell
  • Typical Hold Time
    54 days
$88.32
52W Low: $83.89
10 Mar 2026
52W High: $119.34
27 Jan 2026

BioNTech SE - ADR (BNTX) is currently valued at a market capitalization of $22.66B, with an enterprise value of $6.01B. Over the past 52 weeks, BioNTech SE - ADR has traded between a low of $83.89 and a high of $119.34, highlighting its annual price range. Over the past three months, BioNTech SE - ADR has recorded a drawdown of -21.34%, reflecting recent price volatility. On average, investors hold BioNTech SE - ADR for approximately 54 days, indicating typical investor behavior on the platform.

About BioNTech SE - ADR

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.



People also bought


Global US Market Prices


Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.

Key Stats

  • Market Cap
    $22.66B
  • Sector
    Health
  • 3M Drawdown
    -21.34%
  • Enterprise Value
    $6.01B
  • Dividend Yield
    -
  • Trading Activity
    5% Buy | 95% Sell
  • Typical Hold Time
    54 days
$88.32
52W Low: $83.89
10 Mar 2026
52W High: $119.34
27 Jan 2026

BioNTech SE - ADR (BNTX) is currently valued at a market capitalization of $22.66B, with an enterprise value of $6.01B. Over the past 52 weeks, BioNTech SE - ADR has traded between a low of $83.89 and a high of $119.34, highlighting its annual price range. Over the past three months, BioNTech SE - ADR has recorded a drawdown of -21.34%, reflecting recent price volatility. On average, investors hold BioNTech SE - ADR for approximately 54 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!